https://smoothenedagonistagoni....st.com/measuring-use
RESULTS during the median follow-up of 55 months, median general success (OS) was 22 months. By multivariate analysis, high MLR 0.49 (hazard ratio [HR], 2.37; 95% confidence period [C.I.], 1.39-4.04), large LDH (HR, 1.73; 95% C.I., 1.03-2.9 in the first model, team 2 (hour, 2.74; 95% C.I.;oreover, MLR and composite MLR-LDH could potentially end up in an incremental improvement when you look at the prognostic value of these biomarkers, used as stratification tools for patients with mC
Curtir
Comentario
Compartilhar
